The Living Guidelines: STEMI

# Pharmacotherapy

# Recommendations for Antiplatelet Agents / Anticoagulants Therapy: Aspirin   

## CLASS I
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

## CLASS IIa
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

# Recommendations for Antiplatelet Agents / Anticoagulants Therapy: Clopidogrel   

## CLASS I
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

## CLASS IIa
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

# Recommendations for Antiplatelet Agents / Anticoagulants Therapy: Warfarin   

## CLASS I
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

# Recommendations for Beta Blocker Therapy   

## CLASS I
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

## CLASS IIa
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

## CLASS III
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

# Recommendations for ACE Inhibitors Therapy

## CLASS I
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

## CLASS IIa
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

# Recommendations for Angiotensin Receptor Blockers Therapy

## CLASS I   
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

## CLASS IIb   
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

# Recommendations for Aldosterone Blockers Therapy

## CLASS I   
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

# Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System

## CLASS I   
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

## CLASS IIa   
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

## CLASS IIb   
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

# Recommendations for Influenza Vaccination   

## CLASS I
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

# Reperfusion

# Primary Invasive or Pharmacological Approach   

## CLASS I
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

# Facilitated PCI   

## CLASS IIb
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

## CLASS III
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

# Immediate (or Emergency) Invasive Strategy and Rescue PCI   

## Class I
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

## Class IIa
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

## Class IIb
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

## Class III
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

# PCI after Successful Fibrinolysis or for Patients not Undergoing Primary Reperfusion   

## Class IIb
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

## Class III
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

# Anticoagulants as Ancillary Therapy   

## Class I
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

# Anticoagulants for STEMI patients who do not undergo reperfusion therapy   

## Class IIa
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

## Class III
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

# Thienopyridines   

## Class I
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

## Class IIa
View the Current Guidelines
Make your voice heard: Vote to upgrade, downgrade or keep a recommendation the same
Suggest Revisions to the Guidelines

# Reference
-  Jump up to: 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 Antman EM, Hand M, Armstrong PW;  et al. (2008). "2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee". Circulation. 117 (2): 296329. doi:10.1161/CIRCULATIONAHA.107.188209. PMID 18071078. Unknown parameter |month= ignored (help)CS1 maint: Explicit use of et al. (link) CS1 maint: Multiple names: authors list (link) .mw-parser-output cite.citation{font-style:inherit}.mw-parser-output q{quotes:"\"""\"""'""'"}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-lock-free a{background:url("")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-limited a,.mw-parser-output .cs1-lock-registration a{background:url("")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-subscription a{background:url("")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{display:none;font-size:100%}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}